logo

For the Inventor, By the Inventor

Danvers, MA, United States of America

Robert E Maunus

This inventor holds 5 USPTO granted patents. Top assignee: New England Biolabs, Inc.. Active years: 1997-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert E Maunus. Retrieved from https://idiyas.com/inventor/robert-e-maunus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 60.0

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal5 out of 345 
 
New England Biolabs, Inc.
 patents

Years Active: 1997-2004

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6673588 - Method for cloning and expression of MspA1l restriction endonuclease and MspA1l methylase in E. coli (2004-01-06),
2. 6593122 - Method for cloning and expression of BseRI restriction endonuclease and BseRI methylase in E. coli (2003-07-15),
3. 6586220 - Method for cloning and expression of BsaWI restriction endonuclease and BsaWI methylase in E. coli (2003-07-01),
4. 5885818 - Method for cloning and producing ageI restriction endonuclease in E. (1999-03-23),
5. 5663067 - Method for cloning and producing the SapI restriction endonuclease in E. (1997-09-02),

Title: The Innovations of Robert E. Maunus

Introduction

Robert E. Maunus is a notable inventor based in Danvers, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of recombinant DNA technology. With a total of 5 patents, his work has had a substantial impact on genetic research and applications.

Latest Patents

Maunus's latest patents include a method for cloning and expression of MspA1l restriction endonuclease and MspA1l methylase in E. coli. This invention relates to recombinant DNA coding for the MspA1I restriction endonuclease and MspA1I methylase, as well as their expression in cells containing the recombinant DNA. Another significant patent is the method for cloning and expression of BseRI restriction endonuclease and BseRI methylase in E. coli. This invention focuses on recombinant DNA that encodes the BseRI restriction endonuclease and M.BseRI, along with their expression in cells containing the recombinant DNA.

Career Highlights

Robert E. Maunus is currently associated with New England Biolabs, Inc., where he continues to advance his research and innovations. His work has been instrumental in developing tools that facilitate genetic engineering and molecular biology.

Collaborations

Some of his notable coworkers include Shuang-Yong Xu and Jian-ping Xiao, who have collaborated with him on various projects and research initiatives.

Conclusion

Robert E. Maunus is a distinguished inventor whose contributions to biotechnology have paved the way for advancements in genetic research. His innovative patents and ongoing work at New England Biolabs, Inc. continue to influence the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…